Integrating Electrical and Mechanical Therapies for End-Stage Heart Failure

This webcast showcases footage from the May 5, 2011 symposium Integrating Electrical and Mechanical Therapies for End-Stage Heart Failure. This activity features leading experts in heart failure management who address difficult challenges and case scenarios. This activity will provide Electrophysiologists and others involved in patient care with the latest insight on clinical data concerning the management of advanced heart failure.

Following completion of this activity, participants should be better able to:

Date of Release: June 8, 2011
Term of Approval: June 7, 2012

This activity has been designed to meet the educational needs of:

Michael R. Gold, MD, Ph.D.—Chairman
Medical University of South Carolina
Charleston, SC

David J. Callans, MD, FHRS, CCDS
Hospital of the University of Pennsylvania
Philadelphia, PA

David A. Cesario, MD, PhD
Keck School of Medicine at USC
Los Angeles, CA

Joseph G. Rogers, MD
Duke University Medical Center
Durham, NC

Lynne Warner Stevenson, MD
Harvard Medical School
Boston, MA

Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improve¬ments or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Michael R. Gold, MD, Ph.D.
Consulting fees: Boston Scientific Corporation, Medtronic, Inc., Sorin Group; Fees for non-CME services: Boston Scientific Corporation, Medtronic, Inc., St. Jude Medical, Inc., Thoratec Corporation; Contracted research: Boston Scientific Corporation, Medtronic, Inc., Sorin Group, St. Jude Medical, Inc.

David J. Callans, MD, FHRS, CCDS
Consulting fees: Biosense Webster, Inc., St. Jude Medical, Inc.

David A. Cesario, MD, Ph.D.
Fees for non-CME services: Boston Scientific Corporation, Medtronic, Inc.

Joseph G. Rogers, MD
Consulting fees: Thoratec Corporation

Lynne Warner Stevenson, MD
No financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: The following PIM planners and managers: Jan Hixon, RN, BSN, MA, Trace Hutchison, PharmD, Julia Kimball, RN, BSN, Samantha Mattiucci, PharmD, Jan Schultz, RN, MSN, CCMEP, and Patricia Staples, MSN, NP-C, CCRN hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. Medtelligence, LLC: Ben Caref, PhD, Pamela Clark, BA - No financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months. Heart Rhythm Society: Cynthia R. Roller, BA and Zelda Gilliam, BS – No financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Welcome and Introductions
Michael R. Gold, MD, Ph.D.—Chairman

Management of Ventricular Arrhythmias in Patients with Mechanical Support Devices
David J. Callans, MD, FHRS, CCDS

Cardiac Rhythm Device Interactions with VADs
David A. Cesario, MD, Ph.D.

HF-EP management: A case-by-case Approach
Joseph G. Rogers, MD

Role of bridge and destination LVADs in managing advanced heart failure
Lynne Warner Stevenson, MD

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and Medtelligence, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Postgraduate Institute for Medicine designates this enduring activity for a maximum of 2.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is supported by an independent educational grant from Thoratec.

This activity is jointly sponsored by Postgraduate Institute for Medicine and Medtelligence, LLC. This activity is Co-Sponsored by the Heart Rhythm Society

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM), Medtelligence, LLC, the Heart Rhythm Society (HRS) , and Thoratec do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, Medtelligence, HRS, and Thoratec. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

There are no fees for participating and receiving CME credit for this activity. During the period June 8, 2011 through June 7, 2012 participants must read the learning objectives and faculty disclosures and study the educational activity. PIM supports Green CME by offering your Request for Credit online. If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation on www.cmeuniversity.com. On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by Course ID 8078. Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately. Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.

Date of Release: June 8, 2011
Term of Approval: June 7, 2012

Computer Screen with USB Drive Screen resolution of 1024x786 or larger

Sound card and speakers/headphones

Operating System Requirement: Windows Vista; Windows XP Service Pack 2, Windows 7 Intel® Pentium® III 450MHz or faster processor (or equivalent) 128MB or RAM Mac OS Apple Mac OS X 10.4.8 or above Intel Core TM Duo 1.83GHz or faster processor 128MB of RAM Plug-in

Microsoft Silverlight 3 To download Microsoft Silverlight, please visit: http://www.microsoft.com/getsilverlight. If you do not have administrative rights to install browser plug-ins please contact your system administrator for assistance.